why choose us

First received: August 12, 2022

Clinical Trial: CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Breast Cancer

Study Type: Interventional


Official Title: CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population (Pengaruh Genotipe CYP2D6 Terhadap Efektivitas Penggunaan Tamoksifen Untuk Pasien Kanker Payudara ER+ Pada Populasi In

Brief Summary: The utilization of tamoxifen is considerably high in Indonesia, with about 170,000 tamoxifen prescriptions filed in 2015. It is metabolized by the enzyme CYP2D6, resulting in its active metabolite, endoxifen, which has been proven to be effective in the prevention and treatment of breast cancer.Studies showed the CYP2D6 gene has more than 100 variants; some of which are linked with reduced drug activity, while others do not have any pathological implications. The metabolizer profile of these variants is generally…

Read more